The impact of hyperglycemia on risk of severe infections during early period of induction therapy in patients with newly diagnosed multiple myeloma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Jung, Sung Hoon ^a   Jang, Hee Chang ^a   Lee, Seung Shin ^a   Ahn, Jae Sook ^a   Yang, Deok Hwan ^a   Kim, Yeo Kyeoung ^a   Kim, Hyeoung Joon ^a   Lee, Je Jung ^a  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CREATININE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANDIDIASIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTION; FEMALE; HUMAN; HYPERGLYCEMIA; INDUCTION CHEMOTHERAPY; INFECTION RISK; INFECTIOUS COMPLICATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIPLE MYELOMA; PNEUMOCOCCAL INFECTION; PNEUMONIA; RETROSPECTIVE STUDY; ANALYSIS OF VARIANCE; COMPLICATION; MIDDLE AGED; RISK FACTOR; SEPSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; HYPERGLYCEMIA; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS;

EID: 84900027881     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/413149     Document Type: Article

References (25)

1. Nucci M., Anaissie E., Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clinical Infectious Diseases 2009 49 8 1211 1225 2-s2.0-70349898336 10.1086/605664
2. Perri R. T., Hebbel R. P., Oken M. M., Influence of treatment and response status on infection risk in multiple myeloma. The American Journal of Medicine 1981 71 6 935 940 2-s2.0-0019825038
3. Augustson B. M., Begum G., Dunn J. A., Barth N. J., Davies F., Morgan G., Behrens J., Smith A., Child J. A., Drayson M. T., Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party. Journal of Clinical Oncology 2005 23 36 9219 9226 2-s2.0-33644829447 10.1200/JCO.2005.03.2086
4. Ranta F., Avram D., Berchtold S., Düfer M., Drews G., Lang F., Ullrich S., Dexamethasone induces cell death in Insulin-secreting cells, an effect reversed by exendin-4. Diabetes 2006 55 5 1380 1390 2-s2.0-33745319608 10.2337/db05-1220
5. Rizza R. A., Mandarino L. J., Gerich J. E., Cortisol-induced Insulin resistance in man: impaired suppression of Glucose production and stimulation of Glucose utilization due to a postreceptor defect of Insulin action. The Journal of Clinical Endocrinology and Metabolism 1982 54 1 131 138 2-s2.0-0020469555
6. Coderre L., Vallega G. A., Pilch P. F., Chipkin S. R., In vivo effects of dexamethasone and sucrose on Glucose transport (GLUT- 4) protein tissue distribution. American Journal of Physiology-Endocrinology and Metabolism 1996 271 4 E643 E648 2-s2.0-0029911347
7. Weiser M. A., Cabanillas M. E., Konopleva M., Thomas D. A., Pierce S. A., Escalante C. P., Kantarjian H. M., O'Brien S. M., Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer 2004 100 6 1179 1185 2-s2.0-1542314287 10.1002/cncr.20071
8. Ali N. A., O'Brien J. M. Jr., Blum W., Byrd J. C., Klisovic R. B., Marcucci G., Phillips G., Marsh C. B., Lemeshow S., Grever M. R., Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer 2007 110 1 96 102 2-s2.0-34250853452 10.1002/cncr.22777
9. Gabir M. M., Hanson R. L., Dabelea D., Imperatore G., Roumain J., Bennett P. H., Knowler W. C., The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000 23 8 1108 1112 2-s2.0-0033865136
10. Kumar S. K., Rajkumar S. V., Dispenzieri A., Lacy M. Q., Hayman S. R., Buadi F. K., Zeldenrust S. R., Dingli D., Russell S. J., Lust J. A., Greipp P. R., Kyle R. A., Gertz M. A., Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008 111 5 2516 2520 2-s2.0-41949130070 10.1182/blood-2007-10-116129
11. Brenner H., Gondos A., Pulte D., Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 2008 111 5 2521 2526 2-s2.0-41949114641 10.1182/blood-2007-08-104984
12. Vesole D. H., Oken M. M., Heckler C., Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study. Leukemia 2012 26 2517 2520
13. Klein N. C., Go C. H., Cunha B. A., Infections associated with steroid use. Infectious Disease Clinics of North America 2001 15 2 423 432 2-s2.0-0034958674
14. Khardori R., Adamski A., Khardori N., Infection, immunity, and hormones/endocrine interactions. Infectious Disease Clinics of North America 2007 21 3 601 615 2-s2.0-34548418555 10.1016/j.idc.2007.06.002
15. Dare J. M., Moppett J. P., Shield J. P., The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer 2013 60 E157 E159
16. Turina M., Fry D. E., Polk H. C. Jr., Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Critical Care Medicine 2005 33 7 1624 1633 2-s2.0-22144434453 10.1097/01.CCM.0000170106.61978.D8
17. Wierusz-Wysocka B., Wysocki H., Wykretowicz A., Klimas R., The influence of increasing Glucose concentrations on selected functions of polymorphonuclear neutrophils. Acta Diabetologica Latina 1988 25 4 283 288 2-s2.0-0024272824
18. Alexiewicz J. M., Kumar D., Smogorzewski M., Klin M., Massry S. G., Polymorphonuclear leukocytes in non-Insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Annals of Internal Medicine 1995 123 12 919 924 2-s2.0-0028807303
19. Dhindsa S., Tripathy D., Mohanty P., Ghanim H., Syed T., Aljada A., Dandona P., Differential effects of Glucose and Alcohol on reactive Oxygen species generation and intranuclear nuclear factor- B in mononuclear cells. Metabolism: Clinical and Experimental 2004 53 3 330 334 2-s2.0-1842453995 10.1016/j.metabol.2003.10.013
20. Perner A., Nielsen S. E., Rask-Madsen J., High Glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Medicine 2003 29 4 642 645 2-s2.0-0037398440
21. Bagdade J. D., Root R. K., Bulger R. J., Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974 23 1 9 15 2-s2.0-0015984043
22. Ooi Y. C., Dagi T. F., Maltenfort M., Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery 2012 71 692 702
23. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R., Intensive Insulin therapy in critically ill patients. The New England Journal of Medicine 2001 345 19 1359 1367 2-s2.0-0035829852 10.1056/NEJMoa011300
24. van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P. J., Milants I., Van Wijngaerden E., Bobbaers H., Bouillon R., Intensive Insulin therapy in the medical ICU. The New England Journal of Medicine 2006 354 5 449 461 2-s2.0-32044465949 10.1056/NEJMoa052521
25. Brunkhorst F. M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., Moerer O., Gruendling M., Oppert M., Grond S., Olthoff D., Jaschinski U., John S., Rossaint R., Welte T., Schaefer M., Kern P., Kuhnt E., Kiehntopf M., Hartog C., Natanson C., Loeffler M., Reinhart K., Intensive Insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine 2008 358 2 125 139 2-s2.0-38049096093 10.1056/NEJMoa070716